
Bridging the Gap: How AI Can Improve Access to Mental Wellness
With the dawn of the COVID-19 pandemic, mental health has become an area of concern, as more than 1 billion humans every year seek help from clinicians and therapists to cure problems such as depression, anxiety, and suicidal thoughts. This inevitable growing pressure has stretched healthcare and therapeutic institutes to choose smarter technologies such as…

Kognic, CEO and Co-founder of Kognic, Daniel Langkilde – AITech Interview
To start, Daniel, could you please provide a brief introduction to yourself and your work at Kognic? I’m an experienced machine-learning expert and passionate about making AI useful for safety critical applications. As CEO and Co-Founder of Kognic, I lead a team of data scientists, developers and industry experts. The Kognic Platform empowers industries from…

Unlocking potential: How AI is transforming drug development and material science
In recent years, artificial intelligence (AI) in the pharmaceutical industry has gained significant traction, especially in the drug discovery field, as this technology can identify and develop new medications, helping AI researchers and pharmaceutical scientists eliminate the traditional and labor-intensive techniques of trial-and-error experimentation and high-throughput screening. The successful application of AI techniques and their…